Development, characterization and use of monoclonal antibodies against sTRAIL: measurement of sTRAIL by ELISA. (Q40765491)

23 September 2017

title

Development, characterization and use of monoclonal antibodies against sTRAIL: measurement of sTRAIL by ELISA. (English)

1 reference

23 September 2017

4

Pål Aukrust

0 references

Terje Espevik

series ordinal

6

object named as

Terje Espevik

1 reference

23 September 2017

5

Stig S Frøland

1 reference

23 September 2017

2

Anders Sundan

1 reference

23 September 2017

Nina Beate Liabakk

1

1 reference

23 September 2017

Sverre Torp

series ordinal

3

1 reference

23 September 2017

publication date

1 January 2002

1 reference

Journal of Immunological Methods

23 September 2017

number of pages

10

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

23 September 2017

volume

259

1 reference

23 September 2017

issue

1-2

1 reference

23 September 2017

page(s)

119-128

1 reference

Serum levels of tumor necrosis factor-alpha (TNF alpha) and soluble TNF receptors in human immunodeficiency virus type 1 infection--correlations to clinical, immunologic, and virologic parameters

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900501-4

Concomitant expression of hepatocyte growth factor/scatter factor and the receptor c-MET in human myeloma cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900501-4

Human dendritic cells mediate cellular apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900501-4

Processing of tumour necrosis factor-α precursor by metalloproteinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900501-4

TRAIL: a molecule with multiple receptors and control mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900501-4

Monocyte-mediated tumoricidal activity via the tumor necrosis factor-related cytokine, TRAIL.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900501-4

Lipopolysaccharide induces expression of APO2 ligand/TRAIL in human monocytes and macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900501-4

TRAIL/Apo-2-ligand-induced apoptosis in human T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900501-4

Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900501-4

REGULATION OF APO-2 LIGAND/TRAIL EXPRESSION IN NK CELLS—INVOLVEMENT IN NK CELL-MEDIATED CYTOTOXICITY

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900501-4

Interleukin-1 beta converting enzyme-like protease involvement in Fas-induced and activation-induced peripheral blood T cell apoptosis in HIV infection. TNF-related apoptosis-inducing ligand can mediate activation-induced T cell death in HIV infecti

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900501-4

Metalloproteinase-mediated release of human Fas ligand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900501-4

Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: A novel mechanism for the antitumor effects of type I IFNs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900501-4

Continuous cultures of fused cells secreting antibody of predefined specificity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900501-4

Surface expression of TRAIL/Apo-2 ligand in activated mouse T and B cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900501-4

Immunomagnetic isolation of NK and LAK cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900501-4

Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900501-4

Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900501-4

Functional analysis of tumour necrosis factor-alpha-related apoptosis-inducing ligand (TRAIL): cysteine-230 plays a critical role in the homotrimerization and biological activity of this novel tumoricidal cytokine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900501-4

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900501-4

Identification and characterization of a new member of the TNF family that induces apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900501-4

10.1016/S0022-1759(01)00501-4

7 January 2021

Identifiers

DOI

1 reference

23 September 2017

1 reference